PortfoliosLab logo
Instil Bio, Inc. (TIL)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US45783C1018

CUSIP

45783C101

IPO Date

Mar 19, 2021

Highlights

Market Cap

$94.97M

EPS (TTM)

-$11.39

Gross Profit (TTM)

-$1.00M

EBITDA (TTM)

-$40.60M

Year Range

$9.62 - $92.00

Target Price

$113.67

Short %

14.41%

Short Ratio

6.64

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
TIL vs. SMMT TIL vs. PRCT
Popular comparisons:

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Instil Bio, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%December2025FebruaryMarchAprilMay
-97.50%
44.64%
TIL (Instil Bio, Inc.)
Benchmark (^GSPC)

Returns By Period

Instil Bio, Inc. (TIL) returned -30.70% year-to-date (YTD) and 17.81% over the past 12 months.


TIL

YTD

-30.70%

1M

-12.50%

6M

-57.10%

1Y

17.81%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

-3.77%

1M

3.72%

6M

-5.60%

1Y

8.55%

5Y*

14.11%

10Y*

10.45%

*Annualized

Monthly Returns

The table below presents the monthly returns of TIL, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202516.61%-9.70%-13.63%-25.98%2.96%-30.70%
202454.86%1.02%-9.40%0.19%-1.20%-3.74%18.37%14.53%382.58%-52.81%-15.30%-29.06%150.52%
202329.19%-4.52%-14.97%-1.10%-8.20%-8.15%-0.91%-17.38%-5.12%-13.32%-8.68%12.46%-39.52%
2022-32.14%-7.58%0.19%-34.23%-15.06%-23.06%22.08%-7.80%-6.92%-31.82%-59.70%-52.63%-96.32%
2021-5.14%-18.14%-13.30%8.54%-22.10%25.25%-5.17%13.96%7.90%-22.16%-35.29%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of TIL is 65, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of TIL is 6565
Overall Rank
The Sharpe Ratio Rank of TIL is 5656
Sharpe Ratio Rank
The Sortino Ratio Rank of TIL is 8080
Sortino Ratio Rank
The Omega Ratio Rank of TIL is 7575
Omega Ratio Rank
The Calmar Ratio Rank of TIL is 6060
Calmar Ratio Rank
The Martin Ratio Rank of TIL is 5656
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Instil Bio, Inc. (TIL) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Instil Bio, Inc. Sharpe ratios as of May 10, 2025 (values are recalculated daily):

  • 1-Year: 0.11
  • All Time: -0.56

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Instil Bio, Inc. compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Rolling 12-month Sharpe Ratio0.001.002.003.00December2025FebruaryMarchAprilMay
0.11
0.44
TIL (Instil Bio, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Instil Bio, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-97.56%
-7.88%
TIL (Instil Bio, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Instil Bio, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Instil Bio, Inc. was 98.83%, occurring on Dec 7, 2023. The portfolio has not yet recovered.

The current Instil Bio, Inc. drawdown is 97.56%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.83%Mar 29, 2021680Dec 7, 2023
-9.59%Mar 23, 20213Mar 25, 20211Mar 26, 20214

Volatility

Volatility Chart

The current Instil Bio, Inc. volatility is 56.82%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%December2025FebruaryMarchAprilMay
56.82%
6.82%
TIL (Instil Bio, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Instil Bio, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Instil Bio, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 70.4% positive surprise.


-4.00-3.00-2.00-1.000.002021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
-1.08
-3.65
Actual
Estimate

Valuation

The Valuation section provides an overview of how Instil Bio, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for TIL relative to other companies in the Biotechnology industry. Currently, TIL has a P/S ratio of 55,329.8. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for TIL in comparison with other companies in the Biotechnology industry. Currently, TIL has a P/B value of 0.5. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items